A4gnt is crucial for the biosynthesis of gastric-type mucin O-glycans, and its expression is altered in human gastric cancer, where it affects mucin structure and potentially influences bacterial adhesion and immune recognition (Gong et al., 2025; Yamada et al., 2020). Here, MUC5AC is linked to gastric cancer.